login
login

Europe Daily Bulletin No. 12603

18 November 2020
EU RESPONSE TO COVID-19 / Health
Commission gives green light to early purchase of vaccine developed by CureVac
17/11/2020 (Agence Europe)

17/11/2020 (Agence Europe)As announced the day before, the European Commission approved on Tuesday 17 November an early purchase agreement for the candidate vaccine developed by the German company CureVac (see EUROPE B12602A2). The agreement provides for the initial purchase of 225 million doses, with the possibility of adding a further 180 million doses. The Commission also pointed out that it had finalised exploratory discussions with the American company Moderna on 160 million...

Contents

EU RESPONSE TO COVID-19
INSTITUTIONAL
SECTORAL POLICIES
SOCIAL AFFAIRS
ECONOMY - FINANCE - BUSINESS
EXTERNAL ACTION
COUNCIL OF EUROPE
NEWS BRIEFS